Crux Biolabs Pty Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Crux Biolabs Pty Ltd - overview
Established
2011
Location
-, -, Australia
Primary Industry
Biotechnology
About
Based in Melbourne, Australia, and founded in 2011, Crux Biolabs Pty Ltd is a bioanalytical laboratory conducting contract research studies that include vaccines, immunotherapies, immune-oncology, and infectious disease. As of 2022, the firm is headed by its CEO Catherine Osborne. In August 2022, Genesis Capital, along with the company's management, acquired a majority stake in Crux Biolabs Pty Ltd. The firm offers contract-based immunology research services such as bioanalytics, customized biomarker detection, and cell assay development for pre-clinical and clinical studies as well as for academic and biotech research, and development.
Additionally for biomarker detection company provides 49 ELISA kits for academic research and more than 13 kits for pharma and biotech clients. Furthermore, the firm provides Luminex bead assays for biomarker detection. Apart from this company provides PBMC processing, in vitro cell culture, and flow cytometry for cell assays. The August 2022 acquisition may allow Crux Biolabs Pty Ltd to drive a new phase of growth for the company, allowing it to expand in line with global demand for Australian pre-clinical and clinical testing.
Current Investors
Genesis Capital, Leading Technology Group
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.cruxbiolabs.com
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Crux Biolabs Pty Ltd - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Crux Biolabs Pty Ltd | - | ||||||||
| LP Direct | Completed | Crux Biolabs Pty Ltd | - |
Displaying 1 - 2 of 2
Crux Biolabs Pty Ltd - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.